Literature DB >> 8401159

HIV risks for women drug injectors: heroin and amphetamine users compared.

H Klee1.   

Abstract

The incidence of HIV infection among women in Europe and the US is growing rapidly. Women who inject drugs are particularly vulnerable--they may acquire the infection through sharing injecting equipment and through sexual contact with an infected male. Opioids and stimulants are reputed to have different effects upon sexual activity and a sex life enhanced by drugs may increase the risk further. In the context of two larger studies of HIV-related risk behaviours among opioid and amphetamine users in the North West of England, the sexual behaviour and sharing of two groups of female injectors were compared, one whose primary use was heroin, the other amphetamine. Reported incidence of sharing was similar and high. Marked differences were observed in sexual behaviour, amphetamine injectors reporting greater interest in sex and greater frequency of intercourse. However, more of them perceived their personal risk to infection through unprotected sex as negligible. Over 80% in both groups had engaged in unprotected sex in the 6 months prior to interview. Women injectors tend to have injecting partners--more research is needed if health education strategies are to be devised that will protect them.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8401159     DOI: 10.1111/j.1360-0443.1993.tb02124.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  11 in total

1.  Characteristics of heroin and cocaine users unknown to treatment agencies. Results from the Swiss Hidden Population Study.

Authors:  D Hausser; D Kübler; F Dubois-Arber
Journal:  Soz Praventivmed       Date:  1999

2.  Sex-specific determinants of HIV infection among injection drug users in Montreal.

Authors:  J Bruneau; F Lamothe; J Soto; N Lachance; J Vincelette; A Vassal; E L Franco
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

3.  Predictors of methamphetamine injection in out-of-treatment IDUs.

Authors:  Karen F Corsi; Carol F Kwiatkowski; Robert E Booth
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

4.  Factors associated with HIV infection are not the same for all women.

Authors:  E V Boisson; L C Rodrigues
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

5.  Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users.

Authors:  F Molitor; S R Truax; J D Ruiz; R K Sun
Journal:  West J Med       Date:  1998-02

6.  Incidence of HIV and sexually transmitted infections and risk factors for acquisition among young methamphetamine users in northern Thailand.

Authors:  Catherine G Sutcliffe; Apinun Aramrattana; Susan G Sherman; Bangorn Sirirojn; Danielle German; Kanlaya Wongworapat; Vu Minh Quan; Rassamee Keawvichit; David D Celentano
Journal:  Sex Transm Dis       Date:  2009-05       Impact factor: 2.830

7.  The Feasibility of Interventions to Reduce HIV Risk and Drug Use among Heterosexual Methamphetamine Users.

Authors:  Karen F Corsi; Wayne E Lehman; Sung-Joon Min; Shannon P Lance; Nicole Speer; Robert E Booth; Steve Shoptaw
Journal:  J AIDS Clin Res       Date:  2012-06-04

8.  Evaluation of a peer network intervention trial among young methamphetamine users in Chiang Mai, Thailand.

Authors:  Susan G Sherman; Catherine Sutcliffe; Bangorn Srirojn; Carl A Latkin; Apinun Aramratanna; David D Celentano
Journal:  Soc Sci Med       Date:  2008-11-03       Impact factor: 4.634

9.  Methamphetamine dependence and human immunodeficiency virus risk behavior.

Authors:  Richard A Rawson; Rachel Gonzales; Valerie Pearce; Alfonso Ang; Patricia Marinelli-Casey; Julie Brummer
Journal:  J Subst Abuse Treat       Date:  2008-03-07

10.  Patterns of risky behaviors associated with methamphetamine use among young Thai adults: a latent class analysis.

Authors:  Susan G Sherman; Catherine G Sutcliffe; Danielle German; Bangorn Sirirojn; Apinun Aramrattana; David D Celentano
Journal:  J Adolesc Health       Date:  2008-10-29       Impact factor: 5.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.